Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2025-12-25 @ 11:57 AM
NCT ID:
NCT03382561
Group ID:
EG000
Title:
Arm A (Cisplatin/Carboplatin, Etoposide and Nivolumab; CEN)
Description:
Patients receive nivolumab IV at 360 mg over 30 minutes on day 1, carboplatin AUC 5 or 6 IV over 30-60 minutes on day 1 or cisplatin at 75 mg/m2 IV over 60-120 minutes on day 1, and etoposide at 100 mg/m2 IV over 60-120 minutes on days 1-3. Treatment repeats every 21 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients continue to receive nivolumab IV over 30 minutes every 2 weeks for up to 2 years.
Deaths Number Affected:
67
Deaths Number At Risk:
None
Serious Number Affected:
59
Serious Number At Risk:
77
Other Number Affected:
76
Other Number At Risk:
77
Study:
NCT03382561
Results Section:
NCT03382561
Adverse Events Module:
NCT03382561